Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy

Figure 3

Principal Component Analysis (PCA) biplots [ 42 ] of the sensitive (A) and resistant (B) strains of mouse models. Plots show the differences in the metabolic profiles depending on the number of days after the administration of docetaxel. The sensitive strain shows distinct clusters based on the number of days after treatment (A) while the resistant strain does not (B) show such clusters.

Back to article page